tiprankstipranks
Advertisement
Advertisement
Palisade Bio announces topline data from PALI-2108 trial
PremiumThe FlyPalisade Bio announces topline data from PALI-2108 trial
3M ago
Palisade Bio initiated with a Buy at H.C. Wainwright
Premium
The Fly
Palisade Bio initiated with a Buy at H.C. Wainwright
3M ago
Palisade Bio initiated with a Buy at Stifel
Premium
The Fly
Palisade Bio initiated with a Buy at Stifel
4M ago
Palisade Bio announces equity investment from Crohn’s & Colitis Foundation
PremiumThe FlyPalisade Bio announces equity investment from Crohn’s & Colitis Foundation
6M ago
Palisade Bio granted Japanese patent covering PALI-2108
Premium
The Fly
Palisade Bio granted Japanese patent covering PALI-2108
6M ago
Palisade Bio initiated with a Buy at Clear Street
Premium
The Fly
Palisade Bio initiated with a Buy at Clear Street
6M ago
Palisade Bio price target raised to $8 from $2 at Maxim
PremiumThe FlyPalisade Bio price target raised to $8 from $2 at Maxim
7M ago
Palisade Bio appoints Sharon Skare as global head, clinical operations
Premium
The Fly
Palisade Bio appoints Sharon Skare as global head, clinical operations
8M ago
Palisade Bio Terminates Phantom Unit Plan
Premium
Company Announcements
Palisade Bio Terminates Phantom Unit Plan
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100